Arkolith/Insider Trading/CTXR/Form 4

Mazur Leonard L

Executive Chairman, Director, 10% OwnerCitius Pharmaceuticals, Inc. (CTXR) · full profile →Form 4 · filed Aug 10, 2017
Net Buying
Open-Market Buys
$1.7M
Open-Market Sells
$0
Net Open-Market Flow
$1.7M
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 8, 2017Buy(P)421K$4.13$1.7M1.8M
Aug 8, 2017Conversion(C)1.5M$3.09$4.8M3.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 8, 2017Grant(A)1.5M——1.5M
Aug 8, 2017Buy(P)421K$0.01$4K421K
Aug 8, 2017Conversion(C)1.5M——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-17-003817) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Citius Pharmaceuticals, Inc.

Build

Ask your agent about CTXR insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001477932-17-003817"
Ask your agent
Use Arkolith to summarize insider buying and selling at Citius Pharmaceuticals, Inc.
over the last 90 days and cite the filings.